Directory
>
Kris Vaddi
Kris Vaddi
Chief Executive Officer and Founder | Prelude Therapeutics
Wilmington, Delaware, United States
Kris Vaddi
Summary
Kris Vaddi is a seasoned biotechnology executive with extensive experience in leadership roles across various organizations in the life sciences sector. As the Chief Executive Officer and Founder of Prelude Therapeutics, he has demonstrated a commitment to advancing innovative therapies for cancer patients. Kris has also founded Orsenix, showcasing his entrepreneurial spirit and vision for impactful healthcare solutions. His career spans over two decades in the pharmaceutical industry, with significant positions at Incyte and Dupont Pharmaceuticals, where he contributed to strategic advancements in biological products. A graduate of the University of Florida, he holds a strong educational foundation that complements his professional journey. His expertise in oncology, coupled with a background in public relations services, positions him uniquely at the intersection of science and communication. Kris is passionate about leveraging emerging technologies to drive innovation in healthcare.
Kris Vaddi
Work Experience
Chief Executive Officer and Founder at
Prelude Therapeutics
October 2016 - Present
Founder at
Orsenix
June 2014 - Present
Senior Advisor at
Incyte
June 2015 - June 2016
Group Vice President at
Incyte
March 2010 - June 2015
Vice President at
Incyte
January 2002 - March 2010
Director at
DuPont Pharmaceuticals
January 1999 - January 2002
Senior Research Scientist at
SANOFI-AVENTIS AUSTRALIA PTY LTD
June 1995 - September 1999
Scientist at
Proscript Services Inc
January 1994 - January 1995
Kris Vaddi
Education
January 1989 - January 1992
Acharya N.G. Ranga Agricultural University
January 1981 - January 1988
Frequently Asked Questions about Kris Vaddi
What is Kris Vaddi email address?
Kris Vaddi's primary email address is ******@preludetx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kris Vaddi work for?
Kris Vaddi is a Chief Executive Officer and Founder at Prelude Therapeutics, a company specializing in Commercial physical research.
Where Kris Vaddi graduated from?
Kris Vaddi holds a degree in from University of Florida.
How can I directly contact Kris Vaddi?
To contact Kris Vaddi directly, you can use the email address ******@preludetx.com. Complete contact information is available upon registration with Muraena.
Who is Kris Vaddi?
Kris Vaddi is a seasoned biotechnology executive with extensive experience in leadership roles across various organizations in the life sciences sector. As the Chief Executive Officer and Founder of Prelude Therapeutics, he has demonstrated a commitment to advancing innovative therapies for cancer patients. Kris has also founded Orsenix, showcasing his entrepreneurial spirit and vision for impactful healthcare solutions. His career spans over two decades in the pharmaceutical industry, with significant positions at Incyte and Dupont Pharmaceuticals, where he contributed to strategic advancements in biological products. A graduate of the University of Florida, he holds a strong educational foundation that complements his professional journey. His expertise in oncology, coupled with a background in public relations services, positions him uniquely at the intersection of science and communication. Kris is passionate about leveraging emerging technologies to drive innovation in healthcare.
Kris`s contact details
******@preludetx.com
******@incyte.com
Colleagues
Chief Scientific Officer
Chief Chemistry Officer
Vice President EHS, Lab Operations, & Facilities
Chief People Officer
Executive Director, Technical Operations
Vice President, Head of Finance & Controller
Vice President - Drug Discovery
Vice President of Biology
Senior Vice President, Translation Medicine
SVP, Quantitative Clinical Pharmacology